SAPROPTERIN Drug Patent Profile
✉ Email this page to a colleague
When do Sapropterin patents expire, and when can generic versions of Sapropterin launch?
Sapropterin is a drug marketed by Annora Pharma, Dr Reddys, and Endo Operations. and is included in eight NDAs.
The generic ingredient in SAPROPTERIN is sapropterin dihydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sapropterin
A generic version of SAPROPTERIN was approved as sapropterin dihydrochloride by ENDO OPERATIONS on May 10th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SAPROPTERIN?
- What are the global sales for SAPROPTERIN?
- What is Average Wholesale Price for SAPROPTERIN?
Summary for SAPROPTERIN
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 8 |
Drug Prices: | Drug price information for SAPROPTERIN |
DailyMed Link: | SAPROPTERIN at DailyMed |
![SAPROPTERIN drug patent expirations Drug patent expirations by year for SAPROPTERIN](/p/graph/s/t/SAPROPTERIN-patent-expirations.png)
![Drug Prices for SAPROPTERIN](/p/graph/drug-price/SAPROPTERIN.png)